Browsing Tag
dyslipidemia
3 posts
How CRISPR Therapeutics’ one-and-done CTX310 therapy could transform treatment for high cholesterol and triglycerides
Find out how CRISPR Therapeutics’ CTX310 gene-editing therapy achieved profound cholesterol and triglyceride reductions — could it reshape cardiovascular care?
AstraZeneca acquires oral PCSK9 inhibitors from Dogma Therapeutics
Pharma giant AstraZeneca has signed a deal to acquire a preclinical oral PCSK9 inhibitor asset from Dogma Therapeutics,…
NeuroBo, Gemphire merger wrapped up to form neurodegenerative disease company
NeuroBo Pharmaceuticals, a Boston-based clinical-stage pharma company, has wrapped up its previously announced merger with Gemphire Therapeutics, a…